Biosimilars and Patients with Inflammatory Bowel Disease
Test your skills in 3 cases commonly seen in the GI clinic presented by Catherine Bauer, MSN, RN. Kenneth McQuaid, MD, answers common questions about when to prescribe and when to switch patients to a biosimilar. Edward Li, PharmD, compares the efficacy of biosimilars to their reference drugs.
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.